Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - omeprazole - gastro-resistant capsule - 10 milligram(s) - proton pump inhibitors; omeprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - omeprazole - gastro-resistant capsule - 20 milligram(s) - proton pump inhibitors; omeprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - omeprazole - gastro-resistant capsule, hard - 40 milligram(s) - proton pump inhibitors; omeprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; pantoprazole

Ireland - English - HPRA (Health Products Regulatory Authority)

teva pharma b.v. - pantoprazole sodium sesquihydrate - gastro-resistant tablet - 40 milligram(s) - proton pump inhibitors; pantoprazole

Malta - English - Medicines Authority

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - pantoprazole - gastro-resistant tablet - pantoprazole 20 mg - drugs for acid related disorders

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - rabeprazole sodium - gastro-resistant tablet - 10 milligram(s) - proton pump inhibitors; rabeprazole - alimentary tract and metabolism, drugs for peptic ulcer and gastro-oesophageal reflux disease (gord), proton pump inhibitors - it is indicated in:
active duodenal ulcer;
active benign gastric ulcer;
symptomatic erosive or ulcerative gastro-oesophageal reflux disease (gord);
gastro-oesophageal reflux disease, long-term management (gord maintenance);
symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic gord)
zollinger-ellison syndrome;
in combination with appropriate antibacterial therapeutic regimens for the eradication of helicobacter pylori in patients with peptic ulcer disease

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - rabeprazole sodium - gastro-resistant tablet - 20 milligram(s) - proton pump inhibitors; rabeprazole - alimentary tract and metabolism, drugs for peptic ulcer and gastro-oesophageal reflux disease (gord), proton pump inhibitors - it is indicated in:
active duodenal ulcer;
active benign gastric ulcer;
symptomatic erosive or ulcerative gastro-oesophageal reflux disease (gord);
gastro-oesophageal reflux disease, long-term management (gord maintenance);
symptomatic treatment of moderate to very severe gastro-oesophageal reflux disease (symptomatic gord)
zollinger-ellison syndrome;
in combination with appropriate antibacterial therapeutic regimens for the eradication of helicobacter pylori in patients with peptic ulcer disease.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - omeprazole - gastro-resistant capsule - 40mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - omeprazole - gastro-resistant capsule - 10mg